{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:07:30Z","timestamp":1787101650384,"version":"build-2736575974"},"reference-count":168,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cancer immunotherapy, which leverages the immune system to target neoplastic cells, has undergone significant transformation in recent. However, immunotherapy may have negative effects on skeletal muscle function, causing muscle wasting and functional decline in cancer patients. In this study, we review the mechanisms by which immunotherapy influences skeletal muscle, focusing on immune-related myositis, inflammation, and metabolic alterations within the tumor microenvironment (TME). The key methodologies, including biomechanical assessment techniques such as electrical impedance myography and ultrasound imaging, are discussed to provide valuable insights into process that maintain muscle integrity and function in patients receiving immunotherapy. Moreover, the dual effects of immunotherapy on tumor suppression and muscle damage are described, revealing the significance of inflammatory cytokines, immune checkpoints, and metabolic disturbances within the TME. Importantly, we propose combination therapies integrating immunotherapy and nutritional interventions or anti-inflammatory interventions as potential approaches for mitigating muscle wasting. This study highlights the need for deeper investigations to optimize immunotherapy and improve its efficacy in preserving muscle health, thereby improving patient outcomes and quality of life.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1580108","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:43:30Z","timestamp":1746186210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Tumor microenvironment and immune-related myositis: addressing muscle wasting in cancer immunotherapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Shuang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiankai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taihang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: Tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"104588","DOI":"10.3390\/jcm13216537","article-title":"Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions","volume":"206","author":"Hsu","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071440","article-title":"Immune-related adverse events due to cancer immunotherapy: immune mechanisms and clinical manifestations","volume":"16","author":"Casagrande","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-454","article-title":"Immunotherapy-related skeletal muscle weakness in cancer patients: a case series","volume":"10","author":"Amy","year":"2021","journal-title":"Case Reports"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.731798","article-title":"PD-1\/PD-L1 checkpoint inhibitors in tumor immunotherapy","volume":"12","author":"Jiahua","year":"2021","journal-title":"Front Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Ingrid","year":"2021","journal-title":"Nat Rev Dis Prime"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1462","article-title":"Skeletal muscle: A review of molecular structure and function, in health and disease","volume":"12","author":"Mukund","year":"2020","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2024.101260","article-title":"Cancer-associated muscle weakness - From triggers to molecular mechanisms","volume":"97","author":"Shorter","year":"2024","journal-title":"Mol Aspects Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188359","article-title":"Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions","volume":"1873","author":"Siddiqui","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.240466812","article-title":"Cu(II) complex that synergistically potentiates cytotoxicity and an anti-tumor immune response by targeting cellular redox homeostasis","volume":"121","author":"Huang","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12951-025-03116-4","article-title":"Multi-pathway oxidative stress amplification via controllably targeted nanomaterials for photoimmunotherapy of tumors","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/1120009X.2023.2300224","article-title":"The tumor microenvironment: shaping cancer progression and treatment response","volume":"37","author":"Desai","year":"2025","journal-title":"J Chemother"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439807","article-title":"Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41580-024-00794-0","article-title":"Homeostasis control in health and disease by the unfolded protein response","volume":"26","author":"Acosta-Alvear","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00018-024-05331-y","article-title":"Bone-muscle crosstalk under physiological and pathological conditions","volume":"81","author":"Dong","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111640","DOI":"10.1016\/j.jot.2023.07.005","article-title":"Advances in imaging for assessing the design and mechanics of skeletal muscle in vivo","volume":"155","author":"Dick","year":"2023","journal-title":"J Biomech"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060614","article-title":"The evolution of cancer immunotherapy","volume":"9","author":"Khan","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14715\/cmb\/2024.70.5.13","article-title":"Recent advances in immunotherapy in cancer treatment","volume":"70","author":"Patel","year":"2024","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1139\/cjpp-2024-0201","article-title":"Sarcopenia: recent advances for detection, progression, and metabolic alterations along with therapeutic targets","volume":"102","author":"Ali","year":"2024","journal-title":"Can J Physiol Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2022.03.009","article-title":"Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens","volume":"3","author":"Zhang","year":"2023","journal-title":"Fundam Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cytogfr.2024.08.001","article-title":"Targeting PD-1\/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways","volume":"79","author":"Shen","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01571-5","article-title":"CTLA-4 tail fusion enhances CAR-T anti-tumor immunity","volume":"24","author":"Xiaoyu","year":"2023","journal-title":"Nat Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.927153","article-title":"CAR-T cell therapy in hematological Malignancies: current opportunities and challenges","volume":"13","author":"Xiaomin","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"De Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216894","article-title":"Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies","volume":"591","author":"El-Tanani","year":"2024","journal-title":"Cancer Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-024-02214-5","article-title":"Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges","volume":"24","author":"Wang","year":"2025","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.05.032","article-title":"Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B29","doi-asserted-by":"publisher","first-page":"216969","DOI":"10.1016\/j.canlet","article-title":"The opportunities and challenges of using PD-1\/PD-L1 inhibitors for leukemia treatment","volume":"593","author":"Xu","year":"2024","journal-title":"Cancer Lette"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142556","article-title":"Circulating polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) have a biological role in patients with primary myelofibrosis","volume":"16","author":"Campanell","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"122463","DOI":"10.1016\/j.biomaterials","article-title":"Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment","volume":"305","author":"Jin","year":"2024","journal-title":"Biomaterials"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212223","article-title":"Metabolic reprogramming of immune cells in the tumor microenvironment","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-023-03194-0","article-title":"Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s42003-024-06004-z","article-title":"The landscape of immune checkpoint-related long non-coding RNAs core regulatory circuitry reveals implications for immunoregulation and immunotherapy responses","volume":"7","author":"Qu","year":"2024","journal-title":"Commun Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-021-01464-x","article-title":"Epigenetic modulation of anti-tumor immunity for improved cancer immunotherapy","volume":"20","author":"Dai","year":"2021","journal-title":"Mol Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.1038\/s41467-024-54402-y","article-title":"Calcium nanoparticles target and activate T cells to enhance anti-tumor function","volume":"15","author":"Yang","year":"2024","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105301","article-title":"Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective","volume":"107","author":"Liu","year":"2024","journal-title":"EBioMedicine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-024-01091-9","article-title":"Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment","volume":"25","author":"Baharom","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours clinical dilemmas and future trends","volume":"8","author":"Qian","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors updated insights","volume":"24","author":"Besan","year":"2025","journal-title":"Mol Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00727-x","article-title":"The senescence-associated secretory phenotype and its physiological and pathological implications","volume":"25","author":"Boshi","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313173","article-title":"Mechanisms and regulation of cellular senescence","volume":"22","author":"Roger","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13046-022-02555-3","article-title":"Cellular senescence in cancer: clinical detection and prognostic implications","volume":"41","author":"Domen","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00776-z","article-title":"A ganglioside-based immune checkpoint enables senescent cells to evade immunosurveillance during aging","volume":"5","author":"Iltis","year":"2025","journal-title":"Nat Aging"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8043","article-title":"and metabolism","volume":"34","author":"Shmulevich","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"B51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43587-024-00750-9","article-title":"A chimeric peptide promotes immune surveillance of senescent cells in injury, fibrosis, tumorigenesis and aging","volume":"5","author":"Ming","year":"2025","journal-title":"Nat Aging"},{"key":"B52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41467-024-54132-1","article-title":"Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation","volume":"16","author":"Hwang","year":"2025","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02865-7","article-title":"Immune therapeutic strategies for the senescent tumor microenvironment","volume":"132","author":"Yasuda","year":"2025","journal-title":"Br J Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11050853","article-title":"Oxidative stress in cancer immunotherapy: molecular mechanisms and potential applications","volume":"11","author":"Ruolan","year":"2022","journal-title":"Antioxid (Basel)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153712","article-title":"Cascade of immune mechanism and consequences of inflammatory disorders","volume":"91","author":"Megha","year":"2021","journal-title":"Phytomedicine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"30983","DOI":"10.1038\/s41598-024-82105-3","article-title":"Characterising immune-related adverse events in different types of cancer among Chinese patients receiving immune checkpoint inhibitors","volume":"14","author":"Qi","year":"2024","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112177","article-title":"Age-associated inflammation and implications for skeletal muscle responses to exercise","volume":"177","author":"Kunz","year":"2023","journal-title":"Exp Gerontol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Muhamma","year":"2024","journal-title":"Mol Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2025.01.009","article-title":"Nutritional interventions in depression: The role of vitamin D and omega-3 fatty acids in neuropsychiatric health","volume":"45","author":"Muhammad","year":"2025","journal-title":"Clin Nutrition"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041242","article-title":"et al, cisplatin-induced skeletal muscle dysfunction: mechanisms and counteracting therapeutic strategies","volume":"21","author":"Elena","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-025-06291-y","article-title":"New insights on anti-tumor immunity of CD8(+) T cells: cancer stem cells, tumor immune microenvironment and immunotherapy","volume":"23","author":"Yibin","year":"2025","journal-title":"J Transl Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"155864","DOI":"10.1016\/j.prp.2025.15586","article-title":"Exploring immune checkpoint inhibitors: Focus on PD-1\/PD-L1 axis and beyond","volume":"269","author":"Durre","year":"2025","journal-title":"Pathol Res Pract"},{"key":"B63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Danping","year":"2020","journal-title":"Cell Discov"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.01037","article-title":"The impact of immune cells on the skeletal muscle microenvironment during cancer cachexia","volume":"11","author":"Brandon","year":"2020","journal-title":"Front Physiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06389-5","article-title":"Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks","volume":"15","author":"Lingjiao","year":"2024","journal-title":"Cell Death Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00087","article-title":"Divergent roles of inflammation in skeletal muscle recovery from injury","volume":"11","author":"Emily","year":"2020","journal-title":"Front Physiol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102751","article-title":"Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations","volume":"127","author":"Layal","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105807","article-title":"Skeletal muscle atrophy: From mechanisms to treatments","volume":"172","author":"Yin","year":"2021","journal-title":"Pharmacol Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors","volume":"17","author":"Lorenzo","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2024.100652","article-title":"Current advances in immunotherapy for cancer","volume":"12","author":"Indrajit","year":"2024","journal-title":"Oncol Reports"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40147","article-title":"Treatment patterns and outcomes in patients with non-small cell lung cancer","volume":"10","author":"Florent","year":"2024","journal-title":"Heliyon"},{"key":"B72","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12935-022-02816-3","article-title":"Clinical potential of PD-1\/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy","volume":"22","author":"Mohammadsaleh","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B73","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3892\/mmr.2021.12001","article-title":"A combination of PD\u22121\/PD\u2212L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review)","volume":"23","author":"Xian","year":"2021","journal-title":"Mol Med Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127868","article-title":"Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed\/refractory Burkitt\u2019s lymphoma with TP53 mutations","volume":"14","author":"Qi","year":"2023","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111829","article-title":"Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota","volume":"105","author":"Deng","year":"2023","journal-title":"Nutrition"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.arrct.2021.100172","article-title":"What is known about muscle strength reference values for adults measured by hand-held dynamometry: A scoping review","volume":"4","author":"Morin","year":"2022","journal-title":"Arch Rehabil Res Clin Transl"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10366-9","article-title":"Portable fixed dynamometry: towards remote muscle strength measurements in patients with motor neuron disease","volume":"268","author":"Bakers","year":"2021","journal-title":"J Neurol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s42003-023-05204-3","article-title":"Network of muscle fibers activation facilitates inter-muscular coordination, adapts to fatigue and reflects muscle function","volume":"6","author":"Garcia-Retortillo","year":"2023","journal-title":"Commun Biol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2022.04.019","article-title":"Muscle active force-length curve explained by an electrophysical model of interfilament spacing","volume":"121","author":"Rockenfeller","year":"2022","journal-title":"Biophys J"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ptsp.2024.08.004","article-title":"Assessment of hip abductor and adductor muscle strength with fixed-frame dynamometry: Considerations on the use of bilateral and unilateral tasks","volume":"70","author":"Bl\u00e4ttler","year":"2024","journal-title":"Phys Ther Sport"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/nu15224792","article-title":"Bioelectrical impedance analysis (BIA) for the assessment of body composition in oncology: A scoping review","volume":"15","author":"Mariana","year":"2023","journal-title":"Nutrients"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.659048","article-title":"Current limitations of intraoperative ultrasound in brain tumor surgery","volume":"11","author":"Andrej","year":"2021","journal-title":"Front Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiomech.2023.111709","article-title":"What good is a measure of muscle length? The how and why of direct measurements of skeletal muscle motion","volume":"157","author":"Roberts","year":"2023","journal-title":"J Biomech"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/s23094437","article-title":"Novel 3D force sensors for a cost-effective 3D force plate for biomechanical analysis","volume":"23","author":"Miller","year":"2023","journal-title":"Sensors (Basel)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.07.026","article-title":"Second harmonic generation microscopy, biaxial mechanical tests and fiber dispersion models in human skin biomechanics","volume":"185","author":"Alberini","year":"2024","journal-title":"Acta Biomater"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06912-6","article-title":"Updated practice guideline for dual-energy X-ray absorptiometry (DXA)","volume":"52","author":"Slart","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000000965","article-title":"First experience with a whole-body spectral photon-counting CT clinical prototype","volume":"58","author":"Salim","year":"2023","journal-title":"Invest Radiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000000812","article-title":"1.5 vs 3 tesla magnetic resonance imaging: A review of favorite clinical applications for both field strengths-part 1","volume":"56","author":"Fritz","year":"2021","journal-title":"Invest Radiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000000971","article-title":"MR elastography in cancer","volume":"58","author":"Jing","year":"2023","journal-title":"Invest Radiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13395-023-00331-1","article-title":"Electrical impedance myography detects dystrophin-related muscle changes in mdx mice","volume":"13","author":"Tetsuaki","year":"2023","journal-title":"Skelet Muscle"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae028","article-title":"Making the invisible visible: imaging techniques for assessing muscle mass and muscle quality in chronic kidney disease","volume":"17","author":"Sabatino","year":"2024","journal-title":"Clin Kidney J"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1159\/000525758","article-title":"Evaluation of appendicular muscle mass in sarcopenia in older adults using ultrasonography: A systematic review and meta-analysis","volume":"68","author":"Zhao","year":"2022","journal-title":"Gerontology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/s41598-023-29827-y","article-title":"Total and regional appendicular skeletal muscle mass prediction from dual-energy X-ray absorptiometry body composition models","volume":"13","author":"Mccarthy","year":"2023","journal-title":"Sci Rep"},{"key":"B95","first-page":"e20230003","article-title":"Electrical stimulation for therapeutic approach","volume-title":"Interdiscip Med","author":"Enji","year":"2023"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s10462-022-10209-1","article-title":"A state-of-the-art survey of object detection techniques in microorganism image analysis: from classical methods to deep learning approaches","volume":"56","author":"Ma","year":"2023","journal-title":"Artif Intell Rev"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi8157","article-title":"Programmable and contractile materials through cell encapsulation in fibrous hydrogel assemblies","volume":"7","author":"Davidson","year":"2021","journal-title":"Sci Adv"},{"key":"B98","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41574-020-0377-1","article-title":"Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit","volume":"16","author":"Mcgee","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultras.2024.107465","article-title":"Unveiling the potential of ultrasound in brain imaging: Innovations, challenges, and prospects","volume":"145","author":"Ren","year":"2025","journal-title":"Ultrasonics"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2020.11.014","article-title":"Electrical impedance myography: A critical review and outlook","volume":"132","author":"Sanchez","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/s23104763","article-title":"Skeletal muscle assessment using quantitative ultrasound: A narrative review","volume":"23","author":"Ashir","year":"2023","journal-title":"Sensors (Basel)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122054","article-title":"Assessing engineered tissues and biomaterials using ultrasound imaging: In vitro and in vivo applications","volume":"296","author":"Sebastian","year":"2023","journal-title":"Biomaterials"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi9283","article-title":"Flexible Doppler ultrasound device for the monitoringof blood flow velocity","volume":"7","author":"Wang","year":"2021","journal-title":"Sci Adv"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2020.12.012","article-title":"Muscle composition analysis of ultrasound images: A narrative review of texture analysis","volume":"47","author":"Paris","year":"2021","journal-title":"Ultrasound Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jot.2023.07.005","article-title":"Magnetic resonance imaging techniques for the quantitative analysis of skeletal muscle: State of the art","volume":"42","author":"Engelke","year":"2023","journal-title":"J Orthop Translat"},{"key":"B106","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-823403-7.00027-0","article-title":"Chapter 14 - Ultrasound elastography: in vivo assessment of tissue stiffness","volume-title":"Biomechanics of the Female Reproductive System: Breast and Pelvic Organs","author":"Bou Matar","year":"2023"},{"key":"B107","doi-asserted-by":"publisher","first-page":"24128","DOI":"10.1038\/s41598-021-03221-y","article-title":"Dynamic X-ray elastography using a pulsed photocathode source","volume":"11","author":"Kamezawa","year":"2021","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.666964","article-title":"Potential utility of electrical impedance myography in evaluating age-related skeletal muscle function deficits","volume":"12","author":"Clark","year":"2021","journal-title":"Front Physiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/japplphysiol.00723.2019","article-title":"Resistance exercise training promotes fiber type-specific myonuclear adaptations in older adults","volume":"128","author":"Moro","year":"2020","journal-title":"J Appl Physiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1296341","article-title":"PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment","volume":"14","author":"Parvez","year":"2023","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.09.026","article-title":"PD-L1: From cancer immunotherapy to therapeutic implications in multiple disorders","volume":"32","author":"Lee","year":"2024","journal-title":"Mol Ther"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07357907.2024.2437614","article-title":"Chronic inflammation and cancer: key pathways and targeted therapies","volume":"43","author":"Kapoor","year":"2025","journal-title":"Cancer Invest"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031235","article-title":"Targeting the PD-1\/PD-L1 signaling pathway for cancer therapy: focus on biomarkers","volume":"26","author":"Strati","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193410","article-title":"Tumor-associated macrophages as major immunosuppressive cells in the tumor microenvironment","volume":"16","author":"Ghebremedhin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008669","article-title":"Favorable impact of PD1\/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation","volume":"12","author":"Gassner","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-020-0366-x","article-title":"Small molecule inhibitors targeting the PD-1\/PD-L1 signaling pathway","volume":"42","author":"Wu","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41598-020-58498-2","article-title":"Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1\/PD-L1 checkpoint inhibitors: a multicenter real-life study","volume":"10","author":"Alessio","year":"2020","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.iccn.2024.103934","article-title":"Muscle strength trajectories and outcomes in critically ill patients: A prospective multicentre cohort study","volume":"88","author":"Ting","year":"2025","journal-title":"Intens Crit Care Nurs"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061440","article-title":"CTLA-4 in regulatory T cells for cancer immunotherapy","volume":"13","author":"Navid","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117141","article-title":"Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020\u20132024)","volume":"283","author":"Binbin","year":"2025","journal-title":"Eur J Med Chem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33768","article-title":"Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up","volume":"150","author":"Elin","year":"2022","journal-title":"Int J Cancer"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.07.003","article-title":"Real-world outcome of patients with advanced renal cell carcinoma and intermediate- or poor-risk international metastatic renal cell carcinoma database consortium criteria treated by immune-oncology combinations: differential effectiveness by risk group","volume":"7","author":"Matteo","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1328193","article-title":"Mechanisms underlying immunosuppression by regulatory cells","volume":"15","author":"Oliver","year":"2024","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.22034\/iji.2025.103258.2825","article-title":"Low-dose radiation improves tumor immune microenvironment, enhancing the effects of anti-CTLA-4 therapy","volume":"22","author":"Jigang","year":"2025","journal-title":"Iran J Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107352","article-title":"Chimeric antigen receptor (CAR) T-cell therapy: Harnessing extracellular vesicles for enhanced efficacy","volume":"208","author":"Beatrice","year":"2024","journal-title":"Pharmacol Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Karan","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"B127","doi-asserted-by":"publisher","first-page":"C908","DOI":"10.1152\/ajpcell.00677.2024","article-title":"Tumor metabolism as a factor affecting diversity in cancer cachexia","volume":"328","author":"Oliver","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e20230047","DOI":"10.1002\/INMD.20230047","article-title":"CAR-T-cell products in solid tumors: Progress, challenges, and strategies","volume":"2","author":"Kewen","year":"2024","journal-title":"Interdiscip Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e16","article-title":"Beyond the CAR T cells: TIL therapy for solid tumors","volume":"24","author":"Rohit","year":"2024","journal-title":"Immune Netw"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01207-0","article-title":"CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors","volume":"21","author":"Lei","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.07.002","article-title":"CAR T cell combination therapies to treat cancer","volume":"42","author":"Ugur","year":"2024","journal-title":"Cancer Cell"},{"key":"B132","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43556-022-00109-9","article-title":"TGF-beta signal transduction: biology, function and therapy for diseases","volume":"3","author":"Yan","year":"2022","journal-title":"Mol Biomed"},{"key":"B133","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-024-01625-7","article-title":"Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies","volume":"17","author":"Kexin","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01235-6","article-title":"Transforming growth factor-beta receptors: versatile mechanisms of ligand activation","volume":"45","author":"Chia","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","article-title":"TGF-beta, EMT, and resistance to anticancer treatment","volume":"97","author":"Wang","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/08830185.2024.2411998","article-title":"Transforming growth factor-beta in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting","volume":"44","author":"Hourani","year":"2025","journal-title":"Int Rev Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"7","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.08.002","article-title":"The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-\u03b2 in CAF mediated tumor progression and therapeutic resistance","volume":"520","author":"Chandra","year":"2021","journal-title":"Cancer Lette"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-022-00521-1","article-title":"Tumor in the crossfire: inhibiting TGF-beta to enhance cancer immunotherapy","volume":"36","author":"Tschernia","year":"2022","journal-title":"BioDrugs"},{"key":"B140","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade anti-tumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111046","article-title":"Recent progress in TGF-\u03b2 inhibitors for cancer therapy","volume":"134","author":"Huang","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B142","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41467-020-20289-8","article-title":"TGF\u03b2 signaling curbs cell fusion and muscle regeneration","volume":"12","author":"Francesco","year":"2021","journal-title":"Nat Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-alpha) in autoimmune disease and current TNF-alpha inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B144","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"Van Loo","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10020-025-01089-6","article-title":"Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis","volume":"31","author":"Yang","year":"2025","journal-title":"Mol Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.2174\/1386207324666210715165943","article-title":"TNF-\u03b1 Inhibitors from natural compounds: an overview, CADD approaches, and their exploration for anti-inflammatory agents","volume":"25","author":"Igor Jos\u00e9 Dos Santos","year":"2022","journal-title":"Comb Chem High Throughput Screen"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"216858","DOI":"10.1016\/j.canlet.2024","article-title":"Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer","volume":"591","author":"Jin","year":"2024","journal-title":"Cancer Lett"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.102042","article-title":"Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies","volume":"53","author":"Luo","year":"2023","journal-title":"Nano Today"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2024.2415121","article-title":"Efficacy and safety of combining radiotherapy with immune checkpoint inhibitors in patients with advanced non-small cell lung cancer: a real-world study","volume":"46","author":"Guanli","year":"2024","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/intimm\/dxad042","article-title":"Near-infrared photoimmunotherapy and anticancer immunity","volume":"36","author":"Nakajima","year":"2024","journal-title":"Int Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116930","article-title":"Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials","volume":"177","author":"Zhang","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107074","article-title":"Malnutrition in cancer patients: Causes, consequences and treatment options","volume":"50","author":"Arends","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/nu14204274","article-title":"Effects of an omega-3 supplemented, high-protein diet in combination with vibration and resistance exercise on muscle power and inflammation in old adults: A pilot randomized controlled trial","volume":"14","author":"Ha\u00df","year":"2022","journal-title":"Nutrients"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-01943-7","article-title":"How the amino acid leucine activates the key cell-growth regulator mTOR","volume":"596","author":"Vellai","year":"2021","journal-title":"Nature"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/life12030409","article-title":"Impact of diets on response to immune checkpoint inhibitors (ICIs) therapy against tumors","volume":"12","author":"Zhang","year":"2022","journal-title":"Life (Basel)"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S327378","article-title":"Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures","volume":"15","author":"Peng","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062716","article-title":"The role of the tumor microenvironment (TME) in advancing cancer therapies: immune system interactions, tumor-infiltrating lymphocytes (TILs), and the role of exosomes and inflammasomes","volume":"26","author":"Atef","year":"2025","journal-title":"Int J ecular Sci"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2024.100129","article-title":"Nanomedicine: How nanomaterials are transforming drug delivery, bio-imaging, and diagnosis","volume":"7","author":"Fatma","year":"2025","journal-title":"Next Nanotechnol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.101023","article-title":"Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy","volume":"36","author":"Quan","year":"2021","journal-title":"Nano Today"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190379","article-title":"Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures","volume":"14","author":"Deep","year":"2023","journal-title":"Front Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2024.103223","article-title":"Engineering next-generation chimeric antigen receptor-T cells: recent breakthroughs and remaining challenges in design and screening of novel chimeric antigen receptor variants","volume":"90","author":"Anna","year":"2024","journal-title":"Curr Opin Biotechnol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1039\/d1md00280e","article-title":"Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors","volume":"13","author":"Mohsen","year":"2022","journal-title":"RSC Med Chem"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02444-y","article-title":"Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy","volume":"12","author":"Tao","year":"2024","journal-title":"Leukemia"},{"key":"B165","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s11658-024-00561-1","article-title":"CRISPR\u2013Cas9 applications in T cells and adoptive T cell therapies","volume":"29","author":"Xiaoying","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165823","article-title":"Exercise-induced immune system response: Anti-inflammatory status on peripheral and central organs","volume":"10","author":"D\u00e9bora da","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41467-025-56275-1","article-title":"Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing","volume":"16","author":"Perucca","year":"2025","journal-title":"Nat Commun"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.011","article-title":"Understanding and treating the inflammatory adverse events of cancer immunotherapy","volume":"184","author":"Dougan","year":"2021","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1580108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:43:32Z","timestamp":1746186212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1580108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":168,"alternative-id":["10.3389\/fimmu.2025.1580108"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1580108","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"article-number":"1580108"}}